Agile Therapeutics, Inc.
Q1 2024 13F Holders
Symbol
AGRX
CUSIP
00847L308
Type
Equity
Class
COM
Num filings
1
Total reported value, excl. options
$596.00
Compare 2024 Q1 to
2023 Q4
2023 Q3
2023 Q2
Manager
Report Date
Value ($000)
Shares
Option Type